Sexual Dimorphism in the Growth Hormone and Insulin-Like Growth Factor Axis at Birth
Michael P. P. Geary,
P. Jane Pringle,
Charles H. Rodeck,
John C. P. Kingdom and
Peter C. Hindmarsh
Center for Human Growth and Maturation at the London Center for Pediatric Endocrinology and Metabolism, Department of Obstetrics and Gynecology, University College (C.H.R.), London, United Kingdom W1T 3AA; and Program in Development and Fetal Health, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto (J.C.P.K.), Toronto, Canada
Address all correspondence and requests for reprints to: Dr. P. C. Hindmarsh, Center for Human Growth and Maturation, Cobbold Laboratories, Middlesex Hospital, Mortimer Street, London, United Kingdom W1T 3AA. E-mail: p.hindmarsh{at}ucl.ac.uk.
In rodents and humans there is a sexually dimorphic patternof GH secretion that influences the serum concentration of IGF-I.Pattern differences can be identified in children, but it isnot known how early this difference is established. We studiedthe plasma concentrations of IGF-I, IGF-II, IGF-binding protein-3(BP-3), and GH in cord blood taken from the offspring of 1650singleton Caucasian pregnancies born at term and related thesevalues to birth weight, length, and head circumference. Pregnanciescomplicated by preterm delivery, antepartum hemorrhage, pregnancy-inducedhypertension, preeclampsia, or gestational diabetes and wherecigarette smoking continued were excluded, resulting in a cohortof 987. Cord plasma concentrations of IGF-I, IGF-II, and IGFBP-3were influenced by factors influencing birth size: gestationalage at delivery, mode of delivery, maternal height, and parityof the mother. Plasma GH concentrations were inversely relatedto the plasma concentrations of IGF-I and IGFBP-3; 10.2% ofthe variability in cord plasma IGF-I concentration and 2.7%for IGFBP-3 was explained by sex of the offspring and parity.None of the factors, apart from maternal height, influencedcord serum IGF-II concentrations (adjusted r2 = 1%). Sex ofthe baby, mode of delivery, and parity influenced cord serumGH concentrations (adjusted r2 = 2.6%). Birth weight, length,and head circumference measurements were greater in males thanfemales (P < 0.001). Mean cord plasma concentrations of IGF-I(males, 66.4 ± 1.2 µg/liter; females, 74.5 ±1.3 µg/liter; P < 0.001) and IGFBP-3 (males, 910 ±13 µg/liter; females 978 ± 13 µg/liter; P< 0.001) were significantly lower in males than females.Cord plasma GH concentrations were higher in males than females(males, 30.0 ± 1.2 mU/liter; females, 26.9 ± 1.1mU/liter; P = 0.05), but no difference was noted between thesexes for IGF-II (males, 508 ± 6 µg/liter; females,519 ± 6 µg/liter; P = NS). After adjustment forgestational age, parity, and maternal height, cord plasma concentrationsof IGF-I and IGFBP-3 along with sex explained 38.0% of the variabilityin birth weight, 25.0% in birth length, and 22.7% in head circumference.These data demonstrate that in a group of singleton Caucasianbabies born at term, cord plasma IGF-I, IGFBP-3, and GH concentrationsrelate to birth size, with evidence for sexual dimorphism inthe GH-IGF axis.
This work was supported by grants from the British Heart Foundation,Children Nationwide UK, and Pharmacia-Upjohn (to P.C.H.). J.C.P.K.is funded by the Program in Development and Fetal Health, SamuelLunenfeld Institute, and Department of Obstetrics and Gynecology,Mount Sinai Hospital, University of Toronto.
W Ricart, J Lopez, J Mozas, A Pericot, M A Sancho, N Gonzalez, M Balsells, R Luna, A Cortazar, P Navarro, et al. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses
J Epidemiol Community Health,
January 1, 2009;
63(1):
64 - 68.
[Abstract][Full Text][PDF]
L. Ibanez, G. Sebastiani, A. Lopez-Bermejo, M. Diaz, M. D. Gomez-Roig, and F. de Zegher Gender Specificity of Body Adiposity and Circulating Adiponectin, Visfatin, Insulin, and Insulin Growth Factor-I at Term Birth: Relation to Prenatal Growth
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2774 - 2778.
[Abstract][Full Text][PDF]
M. A. Perrin, H. Chen, D. E. Sandberg, D. Malaspina, and A. S. Brown Growth trajectory during early life and risk of adult schizophrenia
The British Journal of Psychiatry,
December 1, 2007;
191(6):
512 - 520.
[Abstract][Full Text][PDF]
R Verkauskiene, J Beltrand, O Claris, D Chevenne, S Deghmoun, S Dorgeret, M Alison, P Gaucherand, O Sibony, and C Levy-Marchal Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age
Eur. J. Endocrinol.,
November 1, 2007;
157(5):
605 - 612.
[Abstract][Full Text][PDF]
R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2007;
16(9):
1700 - 1712.
[Abstract][Full Text][PDF]
M. A. Hyatt, H. Budge, D. Walker, T. Stephenson, and M. E. Symonds Effects of maternal parity and late gestational nutrition on mRNA abundance for growth factors in the liver of postnatal sheep
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2007;
292(5):
R1934 - R1942.
[Abstract][Full Text][PDF]
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond
Endocr. Rev.,
April 1, 2007;
28(2):
219 - 251.
[Abstract][Full Text][PDF]
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev.,
April 1, 2006;
27(2):
141 - 169.
[Abstract][Full Text][PDF]